Health-economic aspects of glaucoma screening;Gesundheitsökonomische Aspekte des Glaukomscreenings

Ophthalmologe

Volumn 107, Issue 2, 2010, Pages 143-149

  Hirneiss C ^a   Niedermaier, A ^b   Kernt, M ^a   Kampik, A ^a   Neubauer, A S ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b GERMAN AEROSPACE CENTER DLR   (Germany)

Author keywords

Cost utility Analysis; Economic Evaluation; Glaucoma; Screening

Indexed keywords

ADULT; AGED; ARTICLE; BLINDNESS; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; CROSS-SECTIONAL STUDY; EARLY DIAGNOSIS; ECONOMICS; EQUIPMENT DESIGN; FEMALE; GERMANY; GLAUCOMA; HUMAN; INSTRUMENTATION; MALE; MASS SCREENING; MIDDLE AGED; PREDICTION AND FORECASTING; PUBLIC HEALTH; QUALITY ADJUSTED LIFE YEAR; RISK FACTOR; STATISTICAL MODEL;

ADULT; AGED; BLINDNESS; COST-BENEFIT ANALYSIS; CROSS-SECTIONAL STUDIES; EARLY DIAGNOSIS; EQUIPMENT DESIGN; FEMALE; GERMANY; GLAUCOMA; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; MODELS, ECONOMIC; NATIONAL HEALTH PROGRAMS; PREDICTIVE VALUE OF TESTS; QUALITY-ADJUSTED LIFE YEARS; RISK FACTORS;

EID: 77950519218     PISSN: 0941293X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00347-009-1983-4     Document Type: Article

References (27)

1. Aspinall PA, Johnson ZK, Azuara-Blanco A et al (2008) Evaluation of quality of life and priorities of patients with glaucoma. Invest Ophthalmol Vis Sci 49: 1907-1915.
2. Bechetoille A, Arnould B, Bron A et al (2008) Measurement of health-related quality of life with glaucoma: validation of the Glau-QoL 36-item questionnaire. Acta Ophthalmol Scand 86: 71-80.
3. Burr JM, Mowatt G, Hernandez R et al (2007) The clinical effectiveness and cost-effectiveness of screening for open angle glaucoma: a systematic review and economic evaluation. Health Technol Assess 11: iii-iv, ix-x, 1-190.
4. Chang R, Budenz DL (2008) New developments in optical coherence tomography for glaucoma. Curr Opin Ophthalmol 19: 127-135.
5. Hattenhauer MG, Johnson DH, Ing HH et al (1998) The probability of blindness from open-angle glaucoma. Ophthalmology 105: 2099-2104.
6. Hernandez RA, Burr JM, Vale LD (2008) Economic evaluation of screening for open-angle glaucoma. Int J Technol Assess Health Care 24: 203-211.
7. Hirneiss C, Neubauer AS, Tribus C, Kampik A (2006) Value-based medicine in ophthalmology. Ophthalmologe 103: 493-500.
8. Hirneiss C, Neubauer AS, Welge-Lussen U et al (2003) Measuring patient's quality of life in ophthalmology. Ophthalmologe 1001091-1097.
9. Hirth RA, Chernew ME, Miller E et al (2000) Willingness to pay for a quality-adjusted life year: in search of a standard. Med Decis Making 20: 332-342.
10. Hoffmann EM, Bowd C, Klein N et al (2006) Glaucoma detection using the GDx nerve fiber analyzer and the retinal thickness analyzer (RTA). Eur J Ophthalmol 16: 251-258.
11. Hong S, Ahn H, Ha SJ et al (2007) Early glaucoma detection using the Humphrey Matrix Perimeter, GDx VCC, Stratus OCT, and retinal nerve fiber layer photography. Ophthalmology 114: 210-215.
12. Jampel HD (2001) Glaucoma patients' assessment of their visual function and quality of life. Trans Am Ophthalmol Soc 99: 301-317.
13. Jampel HD, Schwartz A, Pollack I et al (2002) Glaucoma patients' assessment of their visual function and quality of life. J Glaucoma 11: 154-163.
14. Kobelt G, Jonsson B, Bergstrom A et al (2006) Cost-effectiveness analysis in glaucoma: what drives utility? Results from a pilot study in Sweden. Acta Ophthalmol Scand 84: 363-371.
15. Laupacis A, Feeny D, Detsky AS, Tugwell PX (1992) How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. CMAJ 146: 473-481.
16. Lee BS, Kymes SM, Nease RF Jr et al (2007) The Impact of Anchor Point on Utilities for 5 Common Ophthalmic Diseases. Ophthalmology.
17. Maier P, Funk J (2006) Diagnostic accuracy of the Retinal Thickness Analyser: differentiation between normal eyes and eyes with glaucoma or macular pathologies. Graefes Arch Clin Exp Ophthalmol 244: 1113-1118.
18. Medeiros FA, Vizzeri G, Zangwill LM et al (2008) Comparison of retinal nerve fiber layer and optic disc imaging for diagnosing glaucoma in patients suspected of having the disease. Ophthalmology 115: 1340-1346.
19. Mowatt G, Burr JM, Cook JA et al (2008) Screening tests for detecting open angle glaucoma: systematic review and meta-analysis. Invest Ophthalmol Vis Sci.
20. Quigley HA, Broman AT (2006) The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 90: 262-267.
21. Sintonen H (2001) The 15D instrument of health-related quality of life: properties and applications. Ann Med 33: 328-336.
22. Tanito M, Itai N, Ohira A, Chihara E (2004) Reduction of posterior pole retinal thickness in glaucoma detected using the Retinal Thickness Analyzer. Ophthalmology 111: 265-275.
23. Toth M, Kothy P, Hollo G (2008) Accuracy of scanning laser polarimetry, scanning laser tomography, and their combination in a glaucoma screening trial. J Glaucoma 17: 639-646.
24. Traverso CE, Walt JG, Kelly SP et al (2005) Direct costs of glaucoma and severity of the disease: a multinational long term study of resource utilisation in Europe. Br J Ophthalmol 89: 1245-1249.
25. Vaahtoranta-Lehtonen H, Tuulonen A, Aronen P et al (2007) Cost effectiveness and cost utility of an organized screening programme for glaucoma. Acta Ophthalmol Scand 85: 508-518.
26. Wilson JMG JG (1968) Principles and practice of screening for disease. Available from: http://www.who.int/bulletin/volumes/86/4/07-050112BP. pdf Genova: WHO.
27. Zanlonghi X, Arnould B, Bechetoille A et al (2003) Glaucoma and quality of life. J Fr Ophtalmol 26 Spec No 2: S39-S44.